Saltar al contenido
Salud cardiovascularEnsayo aleatorizado3 min read

Home blood pressure checks to guide medication lowered systolic pressure in UK trial

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. · Lancet (London, England) · 2018 · Artículo original ↗

Idea principal

In 1182 UK adults with poorly controlled hypertension, home self-monitoring to guide medication changed 12-month systolic pressure by -3.5 mm Hg versus usual care (95% CI -5.8 to -1.2), and adding telemonitoring by -4.7 mm Hg (95% CI -7.0 to -2.4). The trial was unmasked and 15% were missing from the main analysis.

Study design

Ensayo aleatorizado

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Earlier trials of using self-measured blood pressure to adjust antihypertensive medication gave contradictory results, and it is unclear whether telemonitoring adds anything over self-monitoring alone. The TASMINH4 trial set out to test how well self-monitoring, with or without telemonitoring, works for medication adjustment in primary care compared with usual care.

Población y método

Parallel, unmasked randomised controlled trial in 142 UK general practices. Adults older than 35 years with blood pressure higher than 140/90 mm Hg, willing to self-monitor, were randomly assigned 1:1:1 by a secure web-based system to self-monitoring (n=395), self-monitoring with telemonitoring (n=393) or usual care guided by clinic readings (n=394). The primary outcome was clinic-measured systolic blood pressure at 12 months. The primary analysis used available cases (1003 participants, 85%) and sensitivity analyses used multiple imputation.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    At 12 months, mean systolic pressure was 137.0 mm Hg (SD 16.7) with self-monitoring, 136.0 mm Hg (SD 16.1) with telemonitoring and 140.4 mm Hg (SD 16.5) with usual care.
  2. 2
    Compared with usual care, the adjusted mean difference was -3.5 mm Hg for self-monitoring alone (95% CI -5.8 to -1.2) and -4.7 mm Hg for telemonitoring (95% CI -7.0 to -2.4).
  3. 3
    Self-monitoring and telemonitoring did not differ significantly (adjusted mean difference -1.2 mm Hg, 95% CI -3.5 to 1.2).
  4. 4
    Results were similar in sensitivity analyses using multiple imputation, and adverse events were similar in the three groups.

Límites e incertidumbre

  1. 1
    Neither participants nor investigators were masked, which can influence blood pressure management and reporting.
  2. 2
    Only 1003 of 1182 participants (85%) were in the primary analysis, so about 15% had no 12-month result.
  3. 3
    Participants had to be willing to self-monitor, so results may not apply to people who would not.
  4. 4
    Funding included Omron Healthcare UK, a home blood pressure monitor maker, and this reading is based on the abstract only.

Relevancia práctica

Home blood pressure readings used by a clinician to adjust medication produced a modest but real extra drop compared with relying on clinic readings alone, and sending readings by telemonitoring was not clearly better than reading them in the practice. Do not change your own medication from home readings; the benefit here came from clinicians acting on them, so discuss self-monitoring with your clinician.

Tus datos

A validated upper-arm home cuff is the right tool: measure at consistent times, seated and rested, record the readings and share the averages rather than single values. Wrist-worn watches that estimate blood pressure are not what was tested here.

Cómo interpretar la evidencia

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Studies evaluating titration of antihypertensive medication using self-monitoring give contradictory findings and the precise place of telemonitoring over self-monitoring alone is unclear. The TASMINH4 trial aimed to assess the efficacy of self-monitored blood pressure, with or without telemonitoring, for antihypertensive titration in primary care, compared with usual care.

Methods

This study was a parallel randomised controlled trial done in 142 general practices in the UK, and included hypertensive patients older than 35 years, with blood pressure higher than 140/90 mm Hg, who were willing to self-monitor their blood pressure. Patients were randomly assigned (1:1:1) to self-monitoring blood pressure (self-montoring group), to self-monitoring blood pressure with telemonitoring (telemonitoring group), or to usual care (clinic blood pressure; usual care group). Randomisation was by a secure web-based system. Neither participants nor investigators were masked to group assignment. The primary outcome was clinic measured systolic blood pressure at 12 months from randomisation. Primary analysis was of available cases. The trial is registered with ISRCTN, number ISRCTN 83571366.

Findings

1182 participants were randomly assigned to the self-monitoring group (n=395), the telemonitoring group (n=393), or the usual care group (n=394), of whom 1003 (85%) were included in the primary analysis. After 12 months, systolic blood pressure was lower in both intervention groups compared with usual care (self-monitoring, 137·0 [SD 16·7] mm Hg and telemonitoring, 136·0 [16·1] mm Hg vs usual care, 140·4 [16·5]; adjusted mean differences vs usual care: self-monitoring alone, -3·5 mm Hg [95% CI -5·8 to -1·2]; telemonitoring, -4·7 mm Hg [-7·0 to -2·4]). No difference between the self-monitoring and telemonitoring groups was recorded (adjusted mean difference -1·2 mm Hg [95% CI -3·5 to 1·2]). Results were similar in sensitivity analyses including multiple imputation. Adverse events were similar between all three groups.

Interpretation

Self-monitoring, with or without telemonitoring, when used by general practitioners to titrate antihypertensive medication in individuals with poorly controlled blood pressure, leads to significantly lower blood pressure than titration guided by clinic readings. With most general practitioners and many patients using self-monitoring, it could become the cornerstone of hypertension management in primary care.

Funding

National Institute for Health Research via Programme Grant for Applied Health Research (RP-PG-1209-10051), Professorship to RJM (NIHR-RP-R2-12-015), Oxford Collaboration for Leadership in Applied Health Research and Care, and Omron Healthcare UK.

Fuentes y atribución

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial.

McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, Bradburn P, Farmer A, Grant S, Greenfield SM, Heneghan C, Jowett S, Martin U, Milner S, Monahan M, Mort S, Ogburn E, Perera-Salazar R, Shah SA, Yu LM, Tarassenko L, Hobbs FDR, TASMINH4 investigators.

Lancet (London, England) · 2018-02-27

DOI: 10.1016/s0140-6736(18)30309-x ↗PubMed · 29499873 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis observacional

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
Salud cardiovascular →